Safety and Preliminary Evidence of Efficacy Shown for Rogaratinib.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2019-131
Abstract: A phase I trial of the FGFR inhibitor rogaratinib showed safety and efficacy in advanced cancers. read more here.
Keywords: safety preliminary; efficacy shown; efficacy; evidence efficacy ... See more keywords